Sport-related hyperhomocysteinaemia: A putative marker of muscular demand to be noted for cardiovascular risk

British Journal of Sports Medicine

Volumn 42, Issue 11, 2008, Pages 594-600

  Borrione, Paolo ^a,b   Rizzo, M ^c   Spaccamiglio, A ^b   Salvo, R A ^b   Dovio, A ^a   Termine, A ^a   Parisi, A ^c   Fagnani, F ^c   Angeli, A ^a   Pigozzi, F ^c  

^a UNIVERSITY OF TURIN   (Italy)

^b Regional Anti doping Center   (Italy)

^c University Institute of Movement Science   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; CYANOCOBALAMIN; FOLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; INTERLEUKIN 6; LACTATE DEHYDROGENASE;

ADULT; ARTICLE; ATHLETE; BLOOD PRESSURE; BLOOD VESSEL INJURY; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE MARKER; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HYPERHOMOCYSTEINEMIA; MALE; MORBIDITY; MORTALITY; NORMAL HUMAN; PHYSICAL ACTIVITY; SPORT INJURY;

ADULT; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; INTERLEUKIN-6; L-LACTATE DEHYDROGENASE; MALE; MUSCLE, SKELETAL; RISK FACTORS; SPORTS; VITAMIN B 12;

EID: 56549108714     PISSN: 03063674     EISSN: 14730480     Source Type: Journal    
DOI: 10.1136/bjsm.2007.045021     Document Type: Article

References (58)

1. Grundy SM, Pasternak R, Greenland P, et al. AHA/ACC scientific statement. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol 1999;34:1348-59.
2. Warburton DER, Nicol CW, Bredin SSD. Health benefits of physical activity: the evidence. CMAJ 2006;174:801-9.
3. Wegge JK, Roberts CK, Ngo TH, et al. Effect of diet and exercise intervention on inflammatory and adhesion molecules in postmenopausal women on hormone replacement therapy and at risk for coronary artery disease. Metabolism 2004;53:377-81.
4. Maiorana A, O'Driscoll G, Taylor R, et al. Exercise and the nitric oxide vasodilator system. Sports Med 2003;33:1013-35.
5. Hambrecht R, Adams V, Erbs S, et al. Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase. Circulation 2003;107:3152-8.
6. Seidell JC, Cigolini M, Deslypere JP, et al. Body fat distribution in relation to physical activity and smoking habits in 38-year-old European men. The European Fat Distribution Study. Am J Epidemiol 1991;133:257-65.
7. Tremblay A, Despres JP, Leblanc C, et al. Effect of intensity of physical activity on body fatness and fat distribution. Am J Clin Nutr 1990;51:153-7.
8. Ivy JL. Role of exercise training in the prevention and treatment of insulin resistance and non-insulin-dependent diabetes mellitus. Sports Med 1997;24:321-36.
9. Mayer-Davis EJ, D'Agostino R Jr, Karter AJ, et al. Intensity and amount of physical activity in relation to insulin sensitivity: the Insulin Resistance Atherosclerosis Study. JAMA 1998;279:669- 74.
10. Warburton DE, Gledhill N, Quinney A. Musculoskeletal fitness and health. Can J Appl Physiol 2001;26:217-37.
11. Dunn AL, Trivedi MH, O'Neal HA. Physical activity dose-response effects on outcomes of depression and anxiety. Med Sci Sports Exerc 2001;33:S587-97.
12. Einecke D. The athletic career, unfortunately not really atypical. From model athlete to infarct candidate. MMW Fortschr Med 2002;144:6-7.
13. Pipe A. The adverse effects of elite competition on health and well-being. Can J Appl Physiol 2001;26:S192-201.
14. Futterman LG, Myerburg R. Sudden death in athletes. An update. Sports Med 1998;26:335-50.
15. De Cree C, Whiting PH, Cole H. Interactions between homocyst(e)ine and nitric oxide during acute submaximal exercise in adult males. Int J Sports Med 2000;21:256-62.
16. Herrmann M, Schorr H, Obeid R, et al. Homocysteine increases during endurance exercise. Clin Chem Lab Med 2003;41:1518-24.
17. Wright M, Francis K, Cornwell P. Effect of acute exercise on plasma homocysteine. J Sports Med Phys Fitness 1998;38:262-5.
18. Herrmann M, Wilkinson J, Schorr H, et al. Comparison of the influence of volume-oriented training and high-intensity interval training on plasma homocysteine and its cofactors in young, healthy swimmers. Clin Chem Lab Med 2003;41:1525-31.
19. Konig D, Bisse E, Deibert P, et al. Influence of training volume and acute physical exercise on the homocysteine levels in endurance-trained men: interactions with plasma folate and vitamin B12. Ann Nutr Metab 2003;47:114-8.
20. Okura T, Rankinen T, Lussier-Cacan S, et al. Effect of regular aerobic exercise on plasma homocysteine concentrations: The HERITAGE family study. Med Sci Sports Exerc 2004;36:S188-S189.
21. Borrione P, Pigozzi F, Massazza G, et al. Hyperhomocysteinemia in winter elite athletes: a longitudinal study. J Endocrinol Invest 2007;30:367-75.
22. Chambers JC, Seddon MDI, Shah S, et al. Homocysteine-a novel risk factor for vascular disease. J R Soc Med 2001;94:10-13.
23. Boushey CJ, Beresford SA, Omenn GS, et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995;274:1049-57.
24. Stampfer MJ, Malinow MR, Willett WC, et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 1992;268:877-81.
25. The Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 2002;288:2015-22.
26. Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 2002;325:1202.
27. D'Angelo A, Selhub J. Homocysteine and thrombotic disease. Blood 1997;90:1-11.
28. Eikelboom JW, Lonn E, Genest J, et al. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 1999;131:363-75.
29. Sadeghian S, Fallahi F, Salarifar M, et al. Homocysteine, vitamin B12 and folate levels in premature coronary artery disease. BMC Cardiovascular Disorders 2006;26:6-38.
30. Ross R. Atherosclerosis an inflammatory disease. N Engl J Med 1999;340:115-26.
31. Jin L, Caldwell RB, Li-Masters T, et al. Homocysteine induces endothelial dysfunction via inhibition of arginine transport. J Physiol Pharmacol 2007;58:191-206.
32. Chambers JC, McGregor A, Jean M, et al. Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: an effect reversible with vitamin C therapy. Circulation 1999;99:1156-60.
33. Tawakol A, Ornland T, Gerhard M, et al. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation 1997;95:1119-21.
34. Stehouwer CD, Jakobs C. Abnormalities of vascular function in hyperhomocysteinaemia: relationship to atherothrombotic disease. Eur J Pediatr 1998;157:S107-11.
35. Erol A, Cinar MG, Can C, et al. Effect of homocysteine on nitric oxide production in coronary microvascular endothelial cells. Endothelium 2007;13:157-61.
36. Koga T, Claycombe K, Meydani M. Homocysteine increases monocyte and T-cell adhesion to human aortic endothelial cells. Atherosclerosis 2002;161:365-74.
37. Loscalzo J. The oxidant stress of hyperhomocyst(e)inemia. J Clin Invest 1996;98:5-7.
38. Jakubowski H, Zhang L, Bardeguez A, et al. Homocysteine thiolactone and protein homocysteinylation in human endothelial cells:implications for atherosclerosis. Circ Res 2000;87:45-51.
39. Ueland PM, Refsum H. Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy. J Lab Clin Med 1989;114;473-501.
40. Varga EA, Sturm AC, Misita CP, et al. Homocysteine and MTHFR mutations. Relation to thrombosis and coronary artery disease. Circulation 2005;111:e289-e293.
41. Kang SS, Wong PW, Malinow MR. Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. Annu Rev Nutr 1992;12:279- 98.
42. Terzolo M, Allasino B, Bosio S, et al. Hyperhomocysteinemia in patients with Cushing's syndrome. J Clin Endocrinol Metab 2004;89:3745-51.
43. Sacchi E, Tagliabue L, Duca F. High frequency of the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene in Northern Italy. Thromb Haemost 1997;78:963-4.
44. Maron BJ, Epstein SE, Roberts WC. Causes of sudden death in competitive athletes. J Am Coll Cardiol 1986;7:204-14.
45. Thompson PD, Stern MP, Williams P, et al. Incidence of death during jogging in Rhode Island from 1975 to 1980. JAMA 1982;274:2535-8.
46. Ridker PM, Rifai N, Stampfer MJ, et al. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000;101:1767-72.
47. Klerk M, Verhoef P, Clarke R, et al, MTHFR Studies Collaboration Group. MTHFR 677C->T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA 2002;288:2023-31.
48. Medina M, Urdiales JL, Amores-Sánchez MI. Roles of homocysteine in cell metabolism: old and new functions. Eur J Biochem 2001;268:3871-82.
49. Brosnan JT, Brosnan ME. The sulfur-containing amino acids: an overview. J Nutr 2006;136:1636S-40S.
50. Joubert LM, Manore MM. Exercise, nutrition, and homocysteine. Int J of Sport Nutr and Exerc Metab 2006;16:341-61.
51. Stamler JS, Osborne JA, Jaraki O, et al. Adverse vascular effects of homocysteine are modulated by endothelial dysfunction produced by experimental hyperhomocysteinemia in humans. Circulation 1999;100:1161-8.
52. Sesso HD, Paffenbarger RS Jr, Lee IM. Physical activity and coronary heart disease in men: The Harvard Alumni Health Study. Circulation 2000;102:975-80.
53. O'Connor GT, Hennekens CH, Willett WC, et al. Physical exercise and reduced risk of nonfatal myocardial infarction. Am J Epidemiol 1995;142:1147-56.
54. Roberts CK, Barnard RJ. Effects of exercise and diet on chronic disease. J Appl Physiol 2005;98:3-30.
55. Selhub J, Jaques PF, Wilson PW, et al. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993;270:2693-8.
56. Nygard O, Vollset SE, Refsum H, et al. Total plasma homocysteine and cardiovascular profile. The Hordaland Homocysteine study. JAMA 1995;274:1526-33.
57. Jacques PF, Bostom AG, Wilson PWF, et al. Determinants of plasma total homocysteine concentration in the Framingham Offspring Cohort. Am J Clin Nutr 2001;73:613-21.
58. Kluijtmans LA, Young IS, Boreham CA, et al. Genetic and nutritional factors contributing to hyperhomocysteinemia in young adults. Blood 2003;101:2483-8.